McKesson Total Common and Preferred Stock Dividends Paid 2010-2025 | MCK
McKesson annual/quarterly total common and preferred stock dividends paid history and growth rate from 2010 to 2025. Total common and preferred stock dividends paid can be defined as the cash outflow for all company dividends paid out to preferred and common shareholders.
- McKesson total common and preferred stock dividends paid for the quarter ending March 31, 2025 were $-0.345B, a 9.87% increase year-over-year.
- McKesson total common and preferred stock dividends paid for the twelve months ending March 31, 2025 were $-0.843B, a 9.62% increase year-over-year.
- McKesson annual total common and preferred stock dividends paid for 2025 were $-0.345B, a 9.87% increase from 2024.
- McKesson annual total common and preferred stock dividends paid for 2024 were $-0.314B, a 7.53% increase from 2023.
- McKesson annual total common and preferred stock dividends paid for 2023 were $-0.292B, a 5.42% increase from 2022.
McKesson Annual Total Common and Preferred Stock Dividends Paid
(Millions of US $) |
| 2025 |
$-345 |
| 2024 |
$-314 |
| 2023 |
$-292 |
| 2022 |
$-277 |
| 2021 |
$-276 |
| 2020 |
$-294 |
| 2019 |
$-292 |
| 2018 |
$-262 |
| 2017 |
$-253 |
| 2016 |
$-244 |
| 2015 |
$-227 |
| 2014 |
$-214 |
| 2013 |
$-194 |
| 2012 |
$-195 |
| 2011 |
$-171 |
| 2010 |
$-131 |
| 2009 |
$-116 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$86.017B |
$359.051B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
